Status:

RECRUITING

Clinical Outcome of Intra Articular Injection of Autologous Platelet Rich Plasma in Anterior Cruciate Ligament Injury.

Lead Sponsor:

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Conditions:

Anterior Cruciate Ligament

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

This clinical trial will evaluate the effectiveness of platelet-rich plasma (PRP) injections for patients with anterior cruciate ligament (ACL) injury. ACL injuries commonly cause knee instability, pa...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patients of both sexes who are older than 18 years and younger than 50 years
  • 3 or Less than 3-months history of knee injuries
  • ACL injury MRI Grade 1 (Low) and medium Grade 2 (Medium) grade
  • ACL injury associated with Grade 1 or 2 Posterior cruciate ligament (PCL) tear and/or Grade 1 or 2 meniscal tear
  • The Complete Blood Count (CBC) report shows a hemoglobin \> 10gm/dl and platelet count \>150,000/microliter prior to the procedure
  • Capable of comprehending informed consent
  • Exclusion criteria:
  • Patients who have had intra articular corticosteroid injections in the index knee during the last 12 weeks
  • Patients who are taking systemic steroid
  • Patients who are younger than 18 and older than 50 years
  • Those with a history of platelet disorders or on the therapeutic anticoagulant or anti platelet drugs
  • Hemoglobin below 10 gm/dl
  • Platelet count \<150000/microliter
  • Complete tear of both bundles on MRI
  • Grade 3 or more PCL and meniscal tear on MRI
  • Previous or concurrent ligament reconstruction in the index knee joint.
  • Connective tissue disorders like Marfan Syndrome, Ehler-Danlos Syndrome etc.
  • Any inflammatory disease like Rheumatoid Arthritis, spondyloarthritis, gout, pseudogout etc involving the knee joint.

Exclusion

    Key Trial Info

    Start Date :

    August 27 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 26 2026

    Estimated Enrollment :

    52 Patients enrolled

    Trial Details

    Trial ID

    NCT07185802

    Start Date

    August 27 2025

    End Date

    August 26 2026

    Last Update

    September 22 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Bangabandhu Sheikh Mujib Medical University

    Dhaka, Bangladesh, 1000